Assertion certainty 5/5 debate potential 3/5

Mask: Upfront setup fees drove Infusionsoft's monthly churn from 8% to 2%

Clate Mask · 637: Reason Infusionsoft Didn't IPO, Passes $100M ARR, $125M Raised, Helping 45,000 SMB's With Marketing and Sales Automation with CEO Clate Mask · Apr 22, 2017 · at 18:50

Infusionsoft CEO Clate Mask confirms to Nathan Latka that introducing mandatory upfront setup fees drove their monthly gross churn drop from 8% to 2%.

0:00 / 0:08exact quote · 8.6s
720p mp4 · rendered on demand · StarZero watermark
“Would you directly associate that upfront fee with being the number one mover of your churn going from eight to two percent? Absolutely.”

quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →

More from Clate Mask

Disclosure
Clate Mask: Infusionsoft is profitable and no longer requires VC funding
“We've grown to a point where we're not dependent on venture capital. We're not dependent on outside revenues or outside funding sources. And we've built a profitable growing business that no longer requires that kind of funding.”
Clate Mask May 27, 2018 ▶ 2:00 1037 Clate Mask on ICON, Infusionsoft IPO, Exit Strategy
Insight
Mask: Companies should always stay private if private capital exists
“We just felt like there's no, it's always better to stay private longer. So if you can and you can get the capital, then do it.”
Clate Mask Apr 22, 2017 ▶ 15:18 637: Reason Infusionsoft Didn't IPO, Passes $100M ARR, $125M Raised, Helping 45,000 SMB's With Marketing and Sales Automation with CEO Clate Mask
Assertion Not checkable as stated
Mask: Infusionsoft improved its LTV:CAC ratio while expanding downmarket
“The LTV CAC is stronger than it was before, which is really great because a lot of times when you serve a less sophisticated customer, your CAC is going to go up or your LTV will go down. That hasn't been the case. We've got a better ratio than we had before.”
Clate Mask Dec 19, 2018 ▶ 11:31 1243 Infusionsoft North of $100m in ARR, Details of Mars Mission to 5m SMB Customers
Disclosure
Mask: Infusionsoft lowered LTV by introducing a $99 price point
“Our LTV has gone down as well because we're bringing on a custom, because we now have a 99 dollar price point and customers who can come in without paying, you know, 250 or 300 dollars out the gate.”
Clate Mask Dec 19, 2018 ▶ 11:52 1243 Infusionsoft North of $100m in ARR, Details of Mars Mission to 5m SMB Customers
Assertion Not checkable as stated
Mask confirms Infusionsoft has surpassed a $100 million revenue run rate
“But yeah, we're over the hundred million revenue rate at this point.”
Clate Mask Dec 19, 2018 ▶ 15:45 1243 Infusionsoft North of $100m in ARR, Details of Mars Mission to 5m SMB Customers
Assertion Not checkable as stated
Mask: Infusionsoft has been cash-flow positive for about a year
“Correct. Have been for about a year.”
Clate Mask May 27, 2018 ▶ 9:42 1037 Clate Mask on ICON, Infusionsoft IPO, Exit Strategy
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 2,600 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.